Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy

Age Range:18 - Any
Start Date:June 19, 2017
End Date:December 2019
Contact:Andrea Arruda, B.S.

Use our guide to learn which trials are right for you!

Collect blood samples and associated clinical data prior to and post radiation treatment.

Exploratory study to collect paired pre- and post-irradiation blood samples from 150

Inclusion Criteria:

1. Male and female patients age 18 or older

2. Diagnosed with a primary rectal or esophageal cancer

3. Planned radiation therapy to the esophagogastric area to a minimum of 4140 cGy for
esophageal/gastroesophageal junction cancer or to pelvis to a minimum of 4500 cGy for
rectal cancer as part of clinical care

4. Combining chemotherapy is allowed

5. ECOG Performance Status 0-2

6. Able to provide written informed consent

Exclusion Criteria:

1. Subjects who have received radiation within three (3) months to esophagogastric or
pelvic areas prior to consent

2. Subjects, who in the opinion of the investigator, may not be able to comply with the
requirements of the study
We found this trial at
Duarte, California 91010
Principal Investigator: Yi-Jen Chen, MD
Phone: 626-256-4673
Duarte, CA
Click here to add this to my saved trials
4700 Sunset Boulevard
Los Angeles, California 90027
Principal Investigator: Michael R. Girvigian, MD
Phone: 323-783-5532
Los Angeles, CA
Click here to add this to my saved trials